<DOC>
	<DOCNO>NCT02595203</DOCNO>
	<brief_summary>The primary objective study : - To determine mass balance recovery ( expired air , urine faeces ) route rate elimination 14C-Debio 1450 . - To determine metabolic profile 14C-Debio 1450 whole blood , plasma , urine faeces . - To determine pharmacokinetics total radioactivity Debio 1450 ( prodrug ) Debio 1452 ( active moiety ) plasma urine .</brief_summary>
	<brief_title>Mass Balance Recovery Metabolic Profile 14C Debio 1450 Following Single Oral Intravenous Doses Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Meets protocolspecified criterion qualification contraception Is willing able remain confine study unit entire duration treatment period comply restriction relate food , drink medication Voluntarily consent participate provide write informed consent prior protocolspecific procedure Has history current use overthecounter medication , dietary supplement , drug ( include nicotine alcohol ) outside protocolspecified parameter Has sign , symptom history condition , per protocol opinion investigator , might compromise : 1. safety wellbeing participant study staff 2. safety wellbeing participant 's offspring ( pregnancy breastfeed ) 3. analysis result</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Bioavailability</keyword>
</DOC>